Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$140,918
+$34,783 QoQ
Shares Held
560
+14.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#3,995
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valued Wealth Advisors LLC holds $708,538 across 11 Drug Manufacturers - General names. ABBV ranks #3 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
657 | $166,858 | |
| 2 | LLY |
ELI LILLY & Co
|
125 | $149,928 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
560 | $140,918 | |
| 4 | MRK |
Merck & Co., Inc.
|
737 | $94,704 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
652 | $82,373 | |
| 6 | AMGN |
Amgen Inc
|
79 | $28,607 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
300 | $17,286 | |
| 8 | AZN |
Astrazeneca PLC
|
58 | $10,997 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,918 | 560 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $106,135 | 488 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $126,583 | 554 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $124,568 | 538 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $102,833 | 554 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $112,302 | 536 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $93,470 | 526 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $176,547 | 894 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $77,527 | 452 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $41,518 | 228 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $16,736 | 108 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||